Author

S. Petiwala

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:genetic perturbation / CRISPR· 1 Approach:machine learning (classical)· 1 Research Focus:synaptic & neural circuits· 1

Frequent Co-Authors

C. Lu· 2 shared A. Vo· 1 shared C. Gekas· 1 shared C. Jeffries· 1 shared C. P. Miller· 1 shared C. Ramathal· 1 shared D. Mitra· 1 shared D. Verduzco· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. Lu

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

TCGADEPMAP -- Mapping Translational Dependencies and Synthetic Lethalities within The Cancer Genome Atlas

X. Shi, C. Gekas, D. Verduzco, S. Petiwala, C. Jeffries, C. Lu, E. Murphy, T. Anton, A. Vo, Z. Xiao, P. Narayanan, M. Barnes, S. Roy, C. Ramathal, M. J. Flister, Z. Dezso

TCGADEPMAP maps translational tumor dependencies and synthetic lethality using TCGA data, identifying novel targets like PAPSS1/2 with clinical implications.

bioRxiv · Mar 24, 2022 · PreprintCancer Biology

VHL Synthetic Lethality Signatures Uncovered by Genotype-specific CRISPR-Cas9 Screens

N. Sun, S. Petiwala, C. Lu, J. E. Hutti, M. Hu, M. Hu, M. H. Domanus, D. Mitra, S. N. Addo, C. P. Miller, N. Chung

The paper uses CRISPR-Cas9 screens in isogenic ccRCC cell lines to identify synthetic lethal partners of VHL, revealing new therapeutic targets for renal cell carcinoma.

bioRxiv · Mar 26, 2019Cancer Biology